Nuvectis Pharma Inc (NVCT)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -6.78M | -4.1M | -5.77M | -6.16M | -6.87M | -4.4M | -4.64M | -4.36M |
Pre Tax Income | -6.7M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M |
Net Income | -6.7M | -4.05M | -5.71M | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -6.78M | -4.1M | -5.77M | -6.16M | -6.87M | -4.4M | -4.64M | -4.36M |
EBITDA | -6.78M | -4.1M | -5.77M | -6.16M | -6.87M | -4.4M | -4.64M | -4.36M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 |
Operating Income | -10k | -12.89M | -19.23M | -22.9M |
Pre Tax Income | -10k | -12.89M | -19.09M | -22.26M |
Net Income | -10k | -12.89M | -19.09M | -22.26M |
Preferred Dividends | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.1 | -2.861 | -1.303 | -1.285 |
EBIT | -10k | -12.89M | -19.23M | -22.9M |
EBITDA | -10k | -12.89M | -19.23M | -22.9M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.